HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Therapeutic response of Plasmodium vivax to chloroquine in Bolivia].

AbstractINTRODUCTION:
Knowledge of the therapeutic efficacy of chloroquine for Plasmodium vivax infections improves the capacity for surveillance of anti-malarial drug resistance.
OBJECTIVE:
The therapeutic efficacy of chloroquine as treatment was evaluated for uncomplicated Plasmodium vivax malaria in Bolivia.
MATERIALS AND METHODS:
An in vivo efficacy study of chloroquine was undertaken in three regions of Bolivia--Riberalta, Guayaramerín and Yacuiba. Two hundred and twenty-three patients (84, 80, and 59 in the three regions, respectively) aged over 5 years old were administered with chloroquine (25 mg/kg/three days) and followed for 28 days. Blood levels of chloroquine and desethylchloroquine were measured on day 2 and on the day of reappearance of parasitemia. The cumulative incidence of treatment failure was calculated using the Kaplan and Meier survival analysis.
RESULTS:
The mean parasitemias (asexual) on day 0 were 6,147 parasites/μl of blood in the Riberalta population, 4,251 in Guayaramerín and 5,214 in Yacuiba. The average blood concentrations of chloroquine-desethylchloroquine during day 2 were 783, 817, and 815 ng/ml, respectively. No treatment failures were observed in Yacuiba, whereas in Riberalta and Guayaramerín, the frequencies of treatment failures were 6.2% and 10%. Blood levels of chloroquine and desethylchloroquine in patients with treatment failure showed values below 70 ng/ml on the day of reappearance of parasitemia.
CONCLUSION:
Resistance of Plasmodium vivax to chloroquine was not demonstrated in three regions of Bolivia.
AuthorsArletta Añez, Dennis Navarro-Costa, Omar Yucra, Cecilia Garnica, Viviana Melgar, Manuel Moscoso, Ricardo Arteaga, Gladys Nakao
JournalBiomedica : revista del Instituto Nacional de Salud (Biomedica) 2012 Oct-Dec Vol. 32 Issue 4 Pg. 527-35 ISSN: 2590-7379 [Electronic] Colombia
Vernacular TitleRespuesta terapéutica de Plasmodium vivax a la cloroquina, en Riberalta, Guayaramerín y Yacuiba, Bolivia.
PMID23715228 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antimalarials
  • Chloroquine
  • desethylchloroquine
Topics
  • Adolescent
  • Adult
  • Animals
  • Antimalarials (blood, therapeutic use)
  • Bolivia (epidemiology)
  • Child
  • Child, Preschool
  • Chloroquine (analogs & derivatives, blood, therapeutic use)
  • Drug Resistance
  • Female
  • Humans
  • Malaria, Vivax (drug therapy, epidemiology, parasitology)
  • Male
  • Middle Aged
  • Parasite Load
  • Parasitemia (drug therapy, epidemiology, parasitology)
  • Plasmodium vivax (drug effects)
  • Pregnancy
  • Pregnancy Complications, Infectious (drug therapy, epidemiology, parasitology)
  • Rural Population
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: